Palani Palaniappan, PhD
Company: Epic Sciences
Job title: Chief Technology Officer
Chockalingam “Palani” Palaniappan is the chief technology officer at Epic Sciences. An accomplished global life sciences innovation executive with more than 20 years of global leadership experience across three multinational corporations, GE Healthcare, Life Technologies, and Terumo BCT, delivering over $500M in career revenue. Palani has a considerable track record in breadth and depth from product, people and process excellence from diverse fields ranging from life sciences tools to MedTech industries. He has helped architect many transformative products at the interface of science and technology for scientific and clinical applications including genomics, proteomics, cell biology tools to patient connected engineering devices in health.
Before joining Epic Sciences, Palani was the executive vice president of Innovation and Development and a board member of the Terumo Global Blood Management at Terumo BCT, a global leader in blood management, therapeutic apheresis, cell therapy and regenerative medicine. Prior to this role, he served as the vice president for Research and Development for Cellular Analysis at Life Technologies. Preceding that, he was the head of Molecular Diagnostics for the Amersham Life Sciences unit of GE Healthcare. Palani has a Ph.D. in the field of biological sciences from Northern Illinois University, followed on by a post-doctoral fellowship at the University of Rochester in HIV biology.
Bridging the GAP in Liquid Biopsies — CTCs & cfDNA: A Comprehensive Approach to Detection & Monitoring of Cancer 10:45 am
• Cancer is a high complexity disease which requires a combination of biological insights from both genotypic and phenotypic analysis to guide precision medicine • Circulating tumor cells (CTCs) and cell free DNA (cfDNA) liquid biopsies enable complementary information for clinical decisions, allowing for diagnosis, accurate prognosis, therapeutic target selection, as well as monitoring response…Read more
day: Day One